MAPI Research Trust provides reliable, comprehensive and up-to-date information services to research scientists, pharmaceutical companies, and governmental health agencies involved in the fields of Patient-Reported Outcomes (PRO) and Epidemiology worldwide.
Home SERVICES Questionnaire Licensing
SF-QUALIVEEN (QUALIVEEN Short Form)

Developed by:
Véronique Bonniaud, Dianne Bryant, Pr. Gordon Guyatt, Pr Bernard Parratte, COLOPLAST (France, Canada) and MAPI Values

Objective:
To assess health-related quality of life of patients with urinary disorders in neurologic conditions

Copyright:
QUALIVEEN SF © 2007 Dr Véronique Bonniaud, Dianne Bryant, Pr Gordon Guyatt, Pr Bernard Parratte and LABORATORIES COLOPLAST. All rights reserved.

Reference publication:
Bonniaud V, Bryant D, Parratte B, Guyatt G. Development and validation of the Short Form of a Urinary Quality of Life Questionnaire: SF-Qualiveen. Journal of Urology; In press


Conditions of use:

1. User Agreement:
User is required to complete and sign a User Agreement in which specific conditions requested by the Authors are detailed.


2. Access fees:

carre6 Authors' royalty fees:

The use of the SF-QUALIVEEN in commercial studies is subject to the Authors' royalty fees:
In commercial clinical studies : 2,000 €* per study + 500 €* per language version

In commercial epidemiological or observational studies:  500 €* per language version + the following per-study fee:
o Up to 1,000 administrations: one-off fee of 2,000 €*
o Between 1,001 à 2,500 administrations: 2 €*/administration
o From 2,500 administrations: 1.80 €*/administration.

Other specific conditions requested by the Authors are detailed in the User Agreement.

carre6 Distribution fees are requested according to the study design and context of use of the questionnaire:
  1. In not-funded academic research (1) and individual clinical practice: free of charge
  2. In funded academic research (2): 300 €* per study + 50 €* per language version.
  3. In commercial studies (3) involving "for-profit" organizations: 600 €* per study + 250 €* per language version.


* excluding VAT

(1) Not funded academic research: if the project is not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds then fees are waived.

(2) Funded academic research: projects receiving funding from commerce, government, EU should anticipate paying the corresponding fees.

(3) Commercial studies (industry, CRO, any for-profit companies) + projects part of a French PHRC (Programme Hospitalier de Recherche Clinique).


Review copy:

English version available for review purpose only. Please click here to access. 


Contact information:

MAPI Research Trust

27 rue de la Villette
F - 69003 LYON
Tel: +33 4 72 13 65 75
Fax: +33 4 72 13 55 73
This e-mail address is being protected from spambots. You need JavaScript enabled to view it


Please have the User Agreement completed, dated and signed and return one original copy to MAPI Research Trust by post. As soon as we receive it, we will process your request.


More information on the SF-QUALIVEEN on PROQOLID


[ BACK ]
 

2012 05 22

To access our catalog, please click here.

 

New questionnaires distributed by MAPI Research Trust

ACCEPT (Chronic Treatment Acceptance Questionnaire)
Registrat MAPI (France) and MAPI Consultancy

ADRQL (Alzheimer Disease Related Quality of Life)
Black Betty S, Kasper Judith D and Rabins Peter V. - Johns Hopkins Medical INstitutions (USA)

Barthel Index
Florence I. Mahoney and Dorothea W. Barthel.

ESS (Epworth Sleepiness Scale)
Murray W. Johns (Australia)

FIRST (Fibromyalgia Rapid Screening Tool)
Serge Perrot & Didier Bouhassira (France)

PDSS-2 (Parkinson's Disease Sleep Scale)
Ray Chaudhuri (UK), Claudia Trenkwalder (Germany), Ralf Kohnen (Germany)

Skindex questionnaire 
Mary-Margaret Chren (USA)

TRIM-D and TRIM-D Device (Treatment Related Impact Measure for Diabetes)
Novo Nordisk (Denmark)